Artificial Intelligence
Global AI in Healthcare Market Report 2021: Market to Reach $35,892.2 Million by 2030
Dublin, March 09, 2021 (GLOBE NEWSWIRE) — The “Global AI in Healthcare Market: Analysis and Forecast, 2021-2030” report has been added to ResearchAndMarkets.com’s offering.
Global AI in Healthcare Market to Reach $35,892.2 Million by 2030
The purpose of the study is to enable the reader to gain a holistic view of the global AI in the healthcare market.
The report constitutes an in-depth analysis of the global AI in the healthcare market, including a thorough analysis of the applications. The study also provides market and business-related information on various products, applications, technologies, and end users. The report considers integrated devices, software, and services related to AI in healthcare.
Expert Insight At present, many companies refrain from venturing into this field as in many cases, companies pursue R&D without knowing whether their concept makes for a viable business model. Currently, most of the companies have their own unique model. However, four years down the line, the competition will be more intense, and the market would witness a repetition of existing services and offerings.
Key Companies Profiled
Activ Surgical, Inc., Atomwise, Inc., Babylon Health, BenevolentAI, Butterfly Network, Inc., Freenome, General Electric Company, International Business Machines Corporation (IBM), Koninklijke Philips N.V., Nuance Communications, Inc., Nvidia Corporation, Olive, Siemens Healthineers AG, Viz.ai, Inc., and Zebra Medical Vision Ltd.
Key Questions Answered in this Report:
Key USPs of the Report
Following are some of the key contents of the report: Funding Scenario
This section encompasses a description of the current funding landscape in the global AI in the healthcare space for key players.
Technology Readiness Index
This section is intended to aid the readers in identifying novel technology opportunities.
Business Model Analysis This section comprises information on the key business models deployed in the market by leading players.
Impact of COVID-19
This section of the report encompasses the following:
In addition, the report provides:
Key Topics Covered:
1 Product Definition
2 Scope of Report 3 Research Methodology 4 Industry Analysis 5 Impact of COVID-19 on Global AI in Healthcare Market 6 Competitive Landscape 7 Global AI in Healthcare Market, 2019-2030 8 Global AI in Healthcare Market (by Product) 9 Global AI in Healthcare Market (by Technology) 10 Global AI in Healthcare Market (by Application) 11 Global AI in Healthcare Market (by End User) 12 Global AI in Healthcare Market (by Region) 13 Case Studies 14 Company Profiles For more information about this report visit https://www.researchandmarkets.com/r/w519c6
2.1 Scope of Study
2.2 Exclusion and Inclusion Criteria
2.3 Key Questions Answered in the Report
3.1 Primary Data Sources
3.2 Secondary Data Sources
3.3 Data Sources Categorization
3.4 Selection Criteria for Company Profiles
3.5 Brief Overview of the Market Estimation Process
3.6 Data Validation
3.7 Assumptions and Limitations
4.1 Industry Ecosystem
4.2 Funding Scenario
4.3 Readiness Index
4.4 Legal and Regulatory Framework
4.4.1 Regulatory Framework in North America
4.4.1.1 U.S.
4.4.1.1.1 Connected Devices
4.4.1.1.2 Mobile Medical Apps (MMAs)
4.4.1.1.3 Software-as-a-Medical-Device (SaMD)
4.4.1.1.3.1 General Considerations for SaMDs
4.4.2 Regulatory Framework in Europe
4.4.3 Regulatory Framework in Asia-Pacific
4.4.3.1 Regulatory Framework in China
4.5 Patent Analysis
4.5.1 Insights About Awaited Technological Advancements
4.5.1.1 Age of AI-Integrated Robotics Surgery
4.5.1.2 Building an Integrated AI-Enabled Health Ecosystem
4.5.2 Patent Filing Trend
5.1 Impact on Adoption of Artificial Intelligence in Healthcare
5.1.1 Futuristic Impact of COVID-19 on AI Adoption in Healthcare
5.2 Key Developments During COVID-19 Pandemic
5.3 Impact on Market Size of Global AI in Healthcare Market
5.3.1 Scenario Comparative Analysis
5.3.2 Impact on Companies in Global AI in Healthcare
5.4 Regional Impact
5.4.1 Impact of Vaccination on Regional AI Activities
5.5 Entry Barriers and Opportunities for Companies Entering Global AI in Healthcare Market
6.1 Market Share Analysis
6.1.1 Market Share for Analysis for Medical Imaging and Diagnosis Autonomous Software Providers
6.1.2 Competitive Benchmarking for Drug Discovery and Clinical Trials
6.2 Key Developments and Strategies
6.2.1 Partnerships, Collaborations, and Agreements
6.2.2 New Offerings
6.2.3 Mergers and Acquisitions
6.2.4 Funding Activities
6.2.5 Regulatory and Legal Activities
6.3 Product Mapping Analysis
6.4 Business Model Analysis
6.5 Pipeline Analysis
7.1 Assumptions and Limitations
7.2 Key Findings and Opportunity Assessment
7.2.1 Key Findings
7.2.2 Opportunity Assessment
7.3 Market Dynamics
7.3.1 Market Growth-Promoting Factors
7.3.1.1 Increasing Complexities of Clinical Decision-Making Leading to Higher Adoption of AI in Diagnostics
7.3.1.2 Progress in Healthcare IT Leading to an Expanding Array of Applications
7.3.1.3 Growing Need for Patient-Centric Care
7.3.1.4 Facilitation of Polypharmacology by AI
7.3.1.5 Growing Applications of AI in Health Informatics
7.3.1.6 Shortage of Healthcare Workforce to Drive Demand for Solutions Requiring Minimum or No Human Intervention
7.3.2 Market Growth Inhibiting Factors
7.3.2.1 Lack of Clearly Defined Regulations
7.3.2.2 Data Security and Privacy Concerns
7.3.2.3 Barriers to Physician’s Adoption of AI
7.3.2.4 Legal Implications of AI Systems
7.3.3 Market Growth Opportunities
7.3.3.1 Capitalizing on Unmet Clinical Demand
7.3.3.2 Enabling Care at Home: Remote Monitoring
7.3.3.3 Leveraging Rapid Development in Deep Learning
7.3.3.4 Unlocking the Combined Potential of AI and Robotics
7.3.4 Impact Analysis
8.1 Overview
8.2 AI-Integrated Hardware
8.3 Software and Services
9.1 Overview
9.2 Machine Learning
9.3 Deep Learning
9.4 Computer Vision
9.5 Natural Language Processing (NLP)
9.6 Others
10.1 Overview
10.2 Medical Imaging and Diagnosis
10.3 Virtual Assistance
10.4 Robot-Assisted Surgery
10.5 Drug Discovery and Clinical Trials
10.6 Data Management
10.7 Telemedicine
10.8 Remote Monitoring and Lifestyle Management
10.9 Others
11.1 Overview
11.2 Healthcare Providers
11.3 Pharmaceutical Companies
11.4 Academic Institutes and Research Centers
11.5 Healthcare Insurance Companies
11.6 Patients
11.7 Others
13.1 Aidoc
13.2 Atomwise, Inc.
13.3 Babylon Health
13.4 Microsoft Corporation
13.5 Teladoc Health, Inc.
14.1 Company Overview
14.2 Role in the Global AI in Healthcare Market
14.3 Recent Developments
14.4 SWOT Analysis
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900